Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA
NCT06600698
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
INM176
Sponsor
Milton S. Hershey Medical Center